SEC Tracker
Get the app

Calidi Biotherapeutics CLDI

Calidi Biotherapeutics (CLDWW) filed an 8-K to report the resignation of its Chief Executive Officer, effective immediately. This unexpected leadership change could create uncertainty and disrupt the company's ongoing clinical trials and commercialization efforts for its novel cancer immunotherapy platform.

Form
8-K
Filed
Importance
Major

Open in the appGet the appView on EDGAR

Get an email when Calidi Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. Orgenesis ORGS public float $8M, Jun 30, 2025
  4. Biovie BIVI public float $8M, Dec 31, 2025
  5. VivoSim Labs VIVS public float $8M, Sep 30, 2025